Forgot Login/Password?
Complete Story
 

News RE: DEA rules to reschedule Hydrocodone

The following information was received from APhA:

DEA will be publishing the Final Rule on hydrocodone rescheduling on Friday, August 22, 2014. Despite strong opposition from APhA and a number of other pharmacy stakeholders, DEA finalized the Rule in substantially the same form as it was proposed, meaning that hydrocodone combination products (HCPs) will be classified as Schedule II drugs. The Final Rule will go into effect in 45 days from the date of its publication in the Federal Register. In its announcement of the Final Rule, DEA noted that it received over 600 comments on the rule and that a “small majority” of commenters endorsed the change. DEA issued a full news release today

When the Final Rule takes effect, it will apply to “all pharmaceuticals containing hydrocodone currently on the market in the United States.” At that time, all Schedule II requirements will become applicable to HCPs, including, but not limited to, the requirements related to DEA registration, security protocols, labeling and packaging, inventory, and recordkeeping and reporting. It is unclear how pharmacists are supposed to treat patients with pending refills for HCPs, but DEA does state that a practitioner may issue multiple Schedule II prescriptions to provide up to a 90-day supply of medication. However, the DEA cautions that practitioners must make their own determinations, “based on sound medical judgment and in accordance with established medical standards,” regarding whether multiple prescriptions are appropriate for a patient.

We continue to review the text of the Final Rule. A more detailed analysis is available August 22 on www.pharmacist.com

Printer-Friendly Version


Get OPA Events via RSS

Events

 February 2019 
SMTWTFS
     12
3456789
10111213
141516
171819
20
21
2223
242526
2728
  
February 26, 2019
8:30AM-4:00PM

2019 Pharmacy Student Legislative Day

March 6, 2019
7:30AM-5:15PM

APhA's Diabetes Care Certificate Training Program for Pharmacists

OPA Office, 2674 Federated Blvd, Columbus, OH 43235

March 21, 2019

Pharmacist Training Program for Long-Acting Injectables

OPA Office - 2674 Federated Blvd, Columbus, OH 43235

April 12-14, 2019

141st OPA Annual Conference & Trade Show

Greater Columbus Convention Center, Columbus, OH

May 16, 2019
11:00AM

Live Webinar: Required OSHA Training for Immunizing Pharmacists